This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Slaughter files opposition to Trump motion to stay US FTC reinstatement

( July 22, 2025, 16:29 GMT | Official Statement) -- MLex Summary: The Trump administration and codefendants at the US Federal Trade Commission do not make a “a strong showing” that they are “likely to succeed on the merits” in overturning the reinstatement of fired Democratic commissioner Rebecca Kelly Slaughter. In opposing the government's motion for a stay on her reinstatement, Slaughter told the US District Court for the District of Columbia that the defendants have also not carried their burden on whether they will be irreparably injured absent a stay. "Instead of identifying any specific harm they will suffer from Commissioner Slaughter’s continued service at the FTC, Defendants (again) rely entirely on the Wilcox and Grundmann stay orders. However, they make no attempt to explain why the potential harms identified in those cases are relevant here," Slaughter's brief said.See attached document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login